Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

NCT00578175 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1851

Enrollment

INDUSTRY

Sponsor class

Conditions

Varicella
Rubella
Mumps
Measles

Interventions

BIOLOGICAL: Priorix-Tetra™ (MMRV vaccine 208136)
BIOLOGICAL: ProQuad®
BIOLOGICAL: Havrix®
BIOLOGICAL: Prevnar®

Sponsor

GlaxoSmithKline